CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its clinical and financial outlook and announced its full-year and fourth quarter 2011 financial results. During the quarter, Infinity continued to advance its diverse pipeline, which targets areas of high unmet patient need where current treatments are either non-existent or inadequate, such as myelofibrosis, chondrosarcoma and non-small cell lung cancer.
